High Falls Advisors, Inc Bristol Myers Squibb CO Transaction History

High Falls Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $174,073 - $225,731	-3,570 Closed	0 $0
Q3 2018 Nov 16, 2018	BUY	$55.19 - $62.25 $197,028 - $222,232	3,570 New	3,570 $222,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $233,600 - $291,156	-4,623 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $119 - $137	2 Added 0.04%	4,623 $292,000
Q4 2017 Feb 16, 2018	BUY	$59.94 - $65.35 $179 - $196	3 Added 0.06%	4,621 $283,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $255,052 - $294,351	4,618	4,618 $294,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on High Falls Advisors, Inc with notifications on news.